168P Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α

Kirsten De Ridder; Hanne Locy; Elisa Piccioni; Miren Zuazo Ibarra; Robin Maximilian Awad; Stefaan Verhulst; Mathias Van Bulck; Yannick De Vlaeminck; Quentin Lecocq; Eva Reijmen; Wout de Mey; Lien De Beck; Thomas Ertveldt; David Escors; Marleen Keyaerts; Karine Breckpot; Cleo Goyvaerts

doi:10.1016/j.annonc.2022.02.200

168P Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α

Kirsten De Ridder, Hanne Locy, Elisa Piccioni, Miren Zuazo Ibarra, Robin Maximilian Awad, Stefaan Verhulst, Mathias Van Bulck, Yannick De Vlaeminck, Quentin Lecocq, Eva Reijmen, Wout de Mey, Lien De Beck, Thomas Ertveldt, David Escors, Marleen Keyaerts, Karine Breckpot, Cleo Goyvaerts

Research output: Contribution to journal › Meeting abstract (Journal)

Original language	English
Pages (from-to)	109-109
Number of pages	1
Journal	Annals of Oncology
Volume	33
Issue number	S2
DOIs	https://doi.org/10.1016/j.annonc.2022.02.200
Publication status	Published - 30 Mar 2022
Event	ESMO-European Lung Cancer Congress - Virtual Duration: 30 Mar 2021 → 2 Apr 2021

Access to Document

10.1016/j.annonc.2022.02.200

Handle.net

Persistent link

Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α
De Ridder, K., Locy, H., Piccioni, E., Zuazo Ibarra, M., Awad, R. M., Verhulst, S., Van Bulck, M., De Vlaeminck, Y., Reijmen, E., de Mey, W., De Beck, L., Ertveldt, T., Escors, D., Keyaerts, M., Breckpot, K. & Goyvaerts, C., 30 Mar 2022.
Research output: Unpublished contribution to conference › Poster

Cite this

De Ridder, K., Locy, H., Piccioni, E., Zuazo Ibarra, M., Awad, R. M., Verhulst, S., Van Bulck, M., De Vlaeminck, Y., Lecocq, Q., Reijmen, E., de Mey, W., De Beck, L., Ertveldt, T., Escors, D., Keyaerts, M., Breckpot, K., & Goyvaerts, C. (2022). 168P Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α. Annals of Oncology, 33(S2), 109-109. https://doi.org/10.1016/j.annonc.2022.02.200

@article{8df2f5020f394435bdd8ccd21dbec884,

title = "168P Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α",

author = "{De Ridder}, Kirsten and Hanne Locy and Elisa Piccioni and {Zuazo Ibarra}, Miren and Awad, {Robin Maximilian} and Stefaan Verhulst and {Van Bulck}, Mathias and {De Vlaeminck}, Yannick and Quentin Lecocq and Eva Reijmen and {de Mey}, Wout and {De Beck}, Lien and Thomas Ertveldt and David Escors and Marleen Keyaerts and Karine Breckpot and Cleo Goyvaerts",

year = "2022",

month = mar,

day = "30",

doi = "10.1016/j.annonc.2022.02.200",

language = "English",

volume = "33",

pages = "109--109",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "S2",

note = "ESMO-European Lung Cancer Congress ; Conference date: 30-03-2021 Through 02-04-2021",

}

De Ridder, K, Locy, H, Piccioni, E, Zuazo Ibarra, M, Awad, RM, Verhulst, S , Van Bulck, M, De Vlaeminck, Y, Lecocq, Q, Reijmen, E, de Mey, W, De Beck, L, Ertveldt, T, Escors, D, Keyaerts, M , Breckpot, K & Goyvaerts, C 2022, '168P Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α', Annals of Oncology, vol. 33, no. S2, pp. 109-109. https://doi.org/10.1016/j.annonc.2022.02.200

TY - JOUR

T1 - 168P Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α

AU - De Ridder, Kirsten

AU - Locy, Hanne

AU - Piccioni, Elisa

AU - Zuazo Ibarra, Miren

AU - Awad, Robin Maximilian

AU - Verhulst, Stefaan

AU - Van Bulck, Mathias

AU - De Vlaeminck, Yannick

AU - Lecocq, Quentin

AU - Reijmen, Eva

AU - de Mey, Wout

AU - De Beck, Lien

AU - Ertveldt, Thomas

AU - Escors, David

AU - Keyaerts, Marleen

AU - Breckpot, Karine

AU - Goyvaerts, Cleo

PY - 2022/3/30

Y1 - 2022/3/30

U2 - 10.1016/j.annonc.2022.02.200

DO - 10.1016/j.annonc.2022.02.200

M3 - Meeting abstract (Journal)

SN - 0923-7534

VL - 33

SP - 109

EP - 109

JO - Annals of Oncology

JF - Annals of Oncology

IS - S2

T2 - ESMO-European Lung Cancer Congress

Y2 - 30 March 2021 through 2 April 2021

ER -